Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

ARK5 is a tumor invasion-associated factor downstream of Akt signaling.

Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T, Esumi H.

Mol Cell Biol. 2004 Apr;24(8):3526-35.

2.

ARK5 is associated with the invasive and metastatic potential of human breast cancer cells.

Chang XZ, Yu J, Liu HY, Dong RH, Cao XC.

J Cancer Res Clin Oncol. 2012 Feb;138(2):247-54. doi: 10.1007/s00432-011-1102-1. Epub 2011 Nov 22.

PMID:
22105900
3.

Strong association of ARK5 with tumor invasion and metastasis.

Kusakai G, Suzuki A, Ogura T, Kaminishi M, Esumi H.

J Exp Clin Cancer Res. 2004 Jun;23(2):263-8.

PMID:
15354411
4.

Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein.

Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Lavin MF, Esumi H.

J Biol Chem. 2003 Jan 3;278(1):48-53. Epub 2002 Oct 29.

5.
6.
7.

Involvement of transforming growth factor-beta 1 signaling in hypoxia-induced tolerance to glucose starvation.

Suzuki A, Kusakai G, Shimojo Y, Chen J, Ogura T, Kobayashi M, Esumi H.

J Biol Chem. 2005 Sep 9;280(36):31557-63. Epub 2005 Jul 13.

8.
9.

Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway.

Choi YA, Lim HK, Kim JR, Lee CH, Kim YJ, Kang SS, Baek SH.

J Biol Chem. 2004 Aug 27;279(35):36579-85. Epub 2004 Jun 25.

10.
11.

NDR2 acts as the upstream kinase of ARK5 during insulin-like growth factor-1 signaling.

Suzuki A, Ogura T, Esumi H.

J Biol Chem. 2006 May 19;281(20):13915-21. Epub 2006 Feb 17.

12.

Signaling pathways used in trabecular matrix metalloproteinase response to mechanical stretch.

Bradley JM, Kelley MJ, Rose A, Acott TS.

Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5174-81.

PMID:
14638714
13.

Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells.

Kim MS, Park MJ, Kim SJ, Lee CH, Yoo H, Shin SH, Song ES, Lee SH.

Int J Oncol. 2005 Sep;27(3):839-46.

PMID:
16077936
14.

Regulation of caspase-6 and FLIP by the AMPK family member ARK5.

Suzuki A, Kusakai G, Kishimoto A, Shimojo Y, Miyamoto S, Ogura T, Ochiai A, Esumi H.

Oncogene. 2004 Sep 16;23(42):7067-75.

PMID:
15273717
15.
16.

Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.

Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY.

Carcinogenesis. 2009 Jul;30(7):1225-33. doi: 10.1093/carcin/bgp111. Epub 2009 May 6.

PMID:
19420016
17.

Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.

Das R, Philip S, Mahabeleshwar GH, Bulbule A, Kundu GC.

IUBMB Life. 2005 Jun;57(6):441-7. Review.

18.

Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.

Matsumoto Y, Tanaka K, Harimaya K, Nakatani F, Matsuda S, Iwamoto Y.

Jpn J Cancer Res. 2001 Apr;92(4):429-38.

PMID:
11346466
19.

Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.

Lunter PC, van Kilsdonk JW, van Beek H, Cornelissen IM, Bergers M, Willems PH, van Muijen GN, Swart GW.

Cancer Res. 2005 Oct 1;65(19):8801-8.

Supplemental Content

Support Center